Cargando…
P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA (B-NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Autores principales: | Roddie, C., Dias, J., O’Reilly, M., Mitsikakou, M., Charalambous, E., Green, L., Vaughan, M., Agliardi, G., Garcia, J., Lewin, E., Lowdell, M., Marzolini, M., Wood, L., Holmes, H., Ngai, Y., Popova, B., Wilson, W., Kunaseelan, S., Spanswick, V., Lowe, H., Ensell, L., Hartley, J., Domning, S., Morley, S., Marafioti, T., Bloor, A., Irvine, D., Orchard, K., Khwaja, A., Linch, D., Pule, M., Peggs, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430282/ http://dx.doi.org/10.1097/01.HS9.0000848692.42285.0c |
Ejemplares similares
-
P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA
por: Roddie, C., et al.
Publicado: (2022) -
Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma
por: Marzolini, Maria A. V., et al.
Publicado: (2021) -
The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology
por: Kastenbaum, Hannah A., et al.
Publicado: (2010) -
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
por: Roddie, Claire, et al.
Publicado: (2021) -
Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
por: St-Pierre, Frédérique, et al.
Publicado: (2022)